Literature DB >> 10466792

Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs.

Anne Marie Szilvay1, Stig-Ove Bøe1, Karl-Henning Kalland1.   

Abstract

Trans-dominant negative mutants of the human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev inhibit the function of wild-type Rev in a dose-dependent manner. This was previously shown to be caused by nuclear retention of the wild-type protein. In the present work, further analysis of the trans-dominant negative effect was performed using cotransfection experiments with different constructs encoding HIV-1 Rev and viral structural proteins together with a plasmid encoding a trans-dominant negative Rev mutant. Thus, one species of pre-mRNA was transcribed from the reporter plasmids. This pre-mRNA was then either spliced or exported by Rev as unspliced RNA for translation of the HIV structural proteins. An immunofluorescence assay and Western blot analysis were used for analysis of protein expression. In situ hybridization was applied for labelling of unspliced mRNA in transfected cells, and RNase protection analysis was used to determine the relative amount of unspliced versus spliced mRNAs. The experiments confirmed that the transdominant negative mutant inhibited nuclear export of unspliced mRNA. It was, in addition, demonstrated for the first time that the trans-dominant negative mutant also affected a Rev-dependent regulatory step connected with viral pre-mRNA splicing. As a consequence, proteins expressed from unspliced and singly spliced HIV mRNAs decreased while there was an increase in protein products encoded by spliced and alternatively spliced mRNAs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466792     DOI: 10.1099/0022-1317-80-8-1965

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.

Authors:  Dusan Cmarko; Stig-Ove Bøe; Catia Scassellati; Anne Marie Szilvay; Svend Davanger; Xiang-Dong Fu; Gunnar Haukenes; Karl-Henning Kalland; Stanislav Fakan
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.

Authors:  Yoshiyuki Hakata; Masami Yamada; Naoto Mabuchi; Hisatoshi Shida
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  A nuclear export signal within the structural Gag protein is required for prototype foamy virus replication.

Authors:  Noémie Renault; Joelle Tobaly-Tapiero; Joris Paris; Marie-Lou Giron; Audrey Coiffic; Philippe Roingeard; Ali Saïb
Journal:  Retrovirology       Date:  2011-01-21       Impact factor: 4.602

4.  Proteolytic activity assayed by subcellular localization switching of a substrate.

Authors:  Anne-Marie Szilvay; Shirley Vanessa Sarria; Monica Mannelqvist; Rein Aasland; Clemens Furnes
Journal:  Biochem Biophys Rep       Date:  2016-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.